HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms

被引:20
作者
Deshpande, Suprit [1 ]
Patil, Shilpa [1 ]
Kumar, Rajesh [1 ]
Hermanus, Tandile [3 ]
Murugavel, Kailapuri G. [2 ]
Srikrishnan, Aylur K. [2 ]
Solomon, Suniti [2 ]
Morris, Lynn [3 ]
Bhattacharya, Jayanta [1 ,4 ]
机构
[1] Translat Hlth Sci & Technol Inst, NCR Biotech Sci Cluster, HIV Vaccine Translat Res Lab, Faridabad, Haryana, India
[2] YRG Care Ctr AIDS Res & Educ, Madras 600113, Tamil Nadu, India
[3] Natl Inst Communicable Dis, Johannesburg, South Africa
[4] Int AIDS Vaccine Initiat, New York, NY USA
关键词
HIV-1; Neutralizing antibody; Envelope; Plasma; GP120 ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; GLYCOSYLATION SITES; ELITE NEUTRALIZER; HUMORAL IMMUNITY; TYPE-1; INFECTION; VIRUS VARIANTS; VARIABLE LOOPS; EPITOPES; BINDING;
D O I
10.1186/s12977-016-0297-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The glycan supersite centered on N332 in the V3 base of the HIV-1 envelope (Env) is a target for broadly neutralizing antibodies (bnAbs) such as PGT121 and PGT128. In this study, we examined the basis of resistance of HIV-1 clade C Envs obtained from broadly cross neutralizing (BCN) plasma of an Indian donor with N332 specificity. Pseudotyped viruses expressing autologous envs were found to be resistant to autologous BCN plasma as well as to PGT121 and PGT128 mAbs despite the majority of Envs containing an intact N332 residue. While resistance of one of the Envs to neutralization by autologous plasma antibodies with shorter V1 loop length was found to be correlated with a N332S mutation, resistance to neutralization of rest of the Envs was found to be associated with longer V1 loop length and acquisition of protective N-glycans. In summary, we show evidence of escape of circulating HIV-1 clade C in an individual from autologous BCN antibodies by three distinct mechanisms.
引用
收藏
页数:9
相关论文
共 35 条
[1]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[2]   Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection [J].
Bunnik, Evelien M. ;
Pisas, Linaida ;
van Nuenen, Ad C. ;
Schuitemaker, Hanneke .
JOURNAL OF VIROLOGY, 2008, 82 (16) :7932-7941
[3]   Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design [J].
Burton, Dennis R. ;
Hangartner, Lars .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34, 2016, 34 :635-659
[4]   Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein [J].
Cao, J ;
Sullivan, N ;
Desjardin, E ;
Parolin, C ;
Robinson, J ;
Wyatt, R ;
Sodroski, J .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9808-9812
[5]   Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies [J].
Chackerian, B ;
Rudensey, LM ;
Overbaugh, J .
JOURNAL OF VIROLOGY, 1997, 71 (10) :7719-7727
[6]   Structure of an unliganded simian immunodeficiency virus gp120 core [J].
Chen, B ;
Vogan, EM ;
Gong, HY ;
Skehel, JJ ;
Wiley, DC ;
Harrison, SC .
NATURE, 2005, 433 (7028) :834-841
[7]   Antigenic conservation and immunogenicity of the HIV coreceptor binding site [J].
Decker, JM ;
Bibollet-Ruche, F ;
Wei, XP ;
Wang, SY ;
Levy, DN ;
Wang, WQ ;
Delaporte, E ;
Peeters, M ;
Derdeyn, CA ;
Allen, S ;
Hunter, E ;
Saag, MS ;
Hoxie, JA ;
Hahn, BH ;
Kwong, PD ;
Robinson, JE ;
Shaw, GM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) :1407-1419
[8]   Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16 [J].
Doores, Katie J. ;
Burton, Dennis R. .
JOURNAL OF VIROLOGY, 2010, 84 (20) :10510-10521
[9]   Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein [J].
Edwards, TG ;
Hoffman, TL ;
Baribaud, F ;
Wyss, S ;
LaBranche, CC ;
Romano, J ;
Adkinson, J ;
Sharron, M ;
Hoxie, JA ;
Doms, RW .
JOURNAL OF VIROLOGY, 2001, 75 (11) :5230-5239
[10]   Biochemically Defined HIV-1 Envelope Glycoprotein Variant Immunogens Display Differential Binding and Neutralizing Specificities to the CD4-binding Site [J].
Feng, Yu ;
Mckee, Krisha ;
Tran, Karen ;
O'Dell, Sijy ;
Schmidt, Stephen D. ;
Phogat, Adhuna ;
Forsell, Mattias N. ;
Hedestam, Gunilla B. Karlsson ;
Mascola, John R. ;
Wyatt, Richard T. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (08) :5673-5686